PETS(PetMed Express, Inc.) 的财务报表:医疗保健,药品零售。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2022-03-31 | FY 截至 2023-03-31 | FY 截至 2024-03-31 | FY 截至 2025-03-31 | FY 截至 2026-03-31 |
|---|---|---|---|---|---|
| 营业收入 | $272.28M | $247.57M | $274.10M | $226.97M | $179.02M |
| 毛利润 | $76.94M | $76.50M | $84.77M | $69.14M | $50.22M |
| 营业利润 | $24.29M | $6.05M | −$8.16M | −$1.53M | −$58.67M |
| 净利润 | $18.72M | $5.14M | −$7.46M | −$6.27M | −$57.29M |
| 经营现金流 | $18.50M | $27.80M | $4.32M | $4.72M | −$28.39M |
| 自由现金流 | $16.75M | $22.54M | −$194.00K | −$395.00K | −$33.01M |
| 摊薄每股收益 | $0.92 | $0.25 | $-0.37 | $-0.30 | $-2.74 |